Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Hearing loss (hearing impairment).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Hearing loss (hearing impairment) |
EPHA10 encodes EPH receptor A10 (1,008 aa). Receptor for members of the ephrin-A family. Binds to EFNA3, EFNA4 and EFNA5 Highest expression in Testis (33.1 TPM) and Colon Transverse (14.7 TPM).
Hearing loss, autosomal dominant 88 is associated with mutations in the EPHA10 gene on chromosome 1.
EPHA10 is classified as a druggable target (Druggable Genome, Kinase, and Tyrosine Kinase categories) with score 0.9.
Genetic testing for EPHA10 is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for hearing loss, autosomal dominant 88.
4 publications have been identified in PubMed for hearing loss, autosomal dominant 88. Kisho has analyzed 3 by research type. Research spans Case Report / Case Series (67%) and Review / Meta-Analysis (33%).
Khandelwal S (2026). [PMID: 41675840](https://pubmed.ncbi.nlm.nih.gov/41675840/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Zhang JJ (2025). [PMID: 40777921](https://pubmed.ncbi.nlm.nih.gov/40777921/). *Pediatr Diabetes*. [Case Report / Case Series]
Patil V (2024). [PMID: 38970134](https://pubmed.ncbi.nlm.nih.gov/38970134/). *Clin Epigenetics*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 6:06 PM UTC
Online Mendelian Inheritance in Man